IL6 and atrial fibrillation: However, compared with the AF group, the expressions of inflammatory biomarkers (TNF-α, IL-1β, IL-6, and IL-10) were downregulated in the AF + edoxaban group and the AF + rivaroxaban group (p < 0.05).